Dr. Ewa Mrozek, MD

Dr. Mrozek practices at Madison Health in London, Ohio, part of Madison Health.

Dr. Mrozek's NPI, 1972518314, was assigned on July 31, 2006. Dr. Mrozek holds Ohio license 35076312.

Dr. Mrozek's primary practice is Madison Health, at 210 North Main Street, London, OH 43140 in Madison County. The practice phone is (740) 845-7000.

Dr. Mrozek's primary practice is Madison Health in London, Ohio, part of Madison Health. Dr. Mrozek is also affiliated with Ohio State University Hospital. The medical group on file is OSUP Community Outreach, LLC. Dmand AI also links Dr. Mrozek to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mrozek practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Mrozek's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Mrozek is licensed in Ohio.

CMS data shows 379 Medicare services from Dr. Mrozek across 4 procedure codes in 2024, all of them office visits, for 163 Medicare patients. Medicare paid $28,776 for them.

CMS counts 163 Medicare patients who saw Dr. Mrozek in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mrozek's median patient age at 70, with 56% women.

In 2024, Dr. Mrozek wrote 431 Medicare Part D claims for 133 patients. 90% of them were for generic drugs. CMS names the drug for 201 of them, across 11 drugs with 11 or more claims each, at $2,157 in total drug cost. In 2023, CMS named 700 claims across 26 drugs.

Dr. Mrozek accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. Mrozek, published from 2010 to 2024. 2012 was the busiest year, with 6. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Infusions, Intravenous. Dr. Mrozek has published most often in Support Care Cancer. Dr. Mrozek's most frequent co-authors are Rachel M. Layman, MD, Robert Wesolowski, MD and Charles L. Shapiro, MD.

Dmand AI links Dr. Mrozek to 8 clinical trials, 5 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 36 general payments to Dr. Mrozek from 18 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 79% of the total. Amgen Inc. paid the most, $140.